Skip to main content
Premium Trial:

Request an Annual Quote

For Coffee or a Drink?

Where do business and science best meet?, asks David Bradley at Sciencebase. He receives a number of reader responses, mostly emphasizing that the two are really inextricably bound. The best, though, is, “Many recipients of advanced degrees seem at a loss to apply their learning, while some who have ties to the industrial community and their areas of specific interest seem to make a more or less sustainable transition between both worlds."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.